Skip to content

Lifecore Biomedical, Inc. LFCR Q4 2025 Annual earnings

Reported August 7, 2025 · After market close

Revenue$36.4MBeat by $11.2M
EPS-$0.10Miss by $0.01
Revenue estimate$25.3M
EPS estimate-$0.09

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$33.1M
EPS estimate-$0.22

Financials

Q4 2025

Income statement

See full
Revenue$36.4M-3.8%
Gross profit$14.0M-19.0%
Net income-$1.1M
EPS (diluted)-$0.03

Balance sheet

See full
Cash & equivalents$8.3M-2.3%
Total debt$11.1M-90.0%
Total equity$1.3M-88.2%
Total assets$239.3M-5.8%

Cash flow

See full
CapEx$2.1M-22.7%

Valuation & ratios

Valuation

as of 05/25/25
See full
Market cap$259.18M+46.4%
Enterprise value$262.04M-6.2%
P/S+0.6×

Profitability

See full
Gross margin31.3%-1.4pp
Net margin-30%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio2.8×+0.8×

Segments

By product

See full
CDMO$23.5M
HA manufacturing$12.9M

Versus estimates

Ask the moment Lifecore Biomedical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lifecore Biomedical, Inc. report Q4 2025 earnings?
Lifecore Biomedical, Inc. (LFCR) reported Q4 2025 earnings on August 7, 2025 after market close.
What were Lifecore Biomedical, Inc.'s Q4 2025 revenue and EPS?
Lifecore Biomedical, Inc. reported revenue of $36.4M and eps of $-0.10 for Q4 2025.
Did Lifecore Biomedical, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $25.3M by $11.2M. EPS missed the consensus estimate of $-0.09 by $0.01.
How did Lifecore Biomedical, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.8% from $37.9M a year earlier and eps grew 75.6% from $-0.41.
Where can I find Lifecore Biomedical, Inc.'s Q4 2025 SEC filings?
You can read the 10-K periodic report (0001005286-25-000108) directly on SEC EDGAR. The filing index links above go to sec.gov.